Cart
sales@molnova.com
Xanthine oxidoreductase-IN-3
Xanthine oxidoreductase-IN-3
Catalog No. M36445
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 of 26.3 nM, suitable for use in acute hyperuricemia studies.
| Size | Price / USD | Stock | Quantity |
| 5MG | 257 | In Stock |
|
| 10MG | 364 | In Stock |
|
| 25MG | 546 | In Stock |
|
| 50MG | 728 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | 1349 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXanthine oxidoreductase-IN-3
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Peng W, et, al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947.?
molnova catalog
related products
-
Xanthine oxidoreduct...
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 of 26.3 nM, suitable for use in acute hyperuricemia studies.
-
Tigulixostat
Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.
-
amflutizole
Amflutizole used for the treatment of gout, and is a Xanthine oxidase inhibitorAmflutizole is a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex.
